Skip to main content

Blood and blood components

Find out how blood and blood components are regulated.

Blood and blood components including haematopoietic progenitor cells and plasma-derived medical products are regulated as prescription medicines under the Therapeutic Goods (Manufacturing Principles) Determination.

  • blood means whole blood collected from a single human donor and processed either for transfusion or further manufacturing
  • blood components means therapeutic components of blood (red cells, white cells, platelets, plasma) that can be prepared by centrifugation, filtration and freezing, but not including haematopoietic progenitor cells
  • plasma derived products (or that contain plasma derived products)
  • recombinant products
  • haematopoietic progenitor cells (HPC) used for haematopoietic reconstitution:
    • HPC means self-renewing or multi-potent stem cells, or both, capable of maturation into haematopoietic lineages, lineage-restricted pluripotent progenitor cells, or committed progenitor cells.
    • Includes HPC derived from cord blood.

Latest articles

Help us improve the Therapeutic Goods Administration site